Locations:
Search
All six patients in the small early phase trial are no longer symptomatic
One-time infusion of investigational CRISPR-Cas9 therapy found to safely reduce LDL cholesterol by 50% and triglycerides by about 55% in Phase 1 trial
Discovery reveals new disease pathway tied to how the heart uses certain fuels to generate energy; Cleveland Clinic to lead next stage of translational research through new cardiovascular genomics initiative
New Avon Office Expands Primary Care Access with Same/Next-Day Appointments, 24/7 Virtual Care
New clinical section and research center aim to integrate genomic discoveries into cardiovascular care
Results highlight the importance of routine cancer screenings, suggest genetic testing should go beyond high-risk groups
Dr. Mihaljevic recognized for organization’s dedication to its global communities; focus on quality and public health
Cleveland was chosen for its expertise and experience in sports medicine and player health
Joint development project aims to improve patient outcomes and advance interventional cardiology toward intelligent, patient-specific procedure planning
International leaders in science, academia and technology shared insights on advancements in healthcare and the future of therapeutics